Cargando…
Treatment of severe psoriasis with infliximab
Psoriasis is a chronic, immune mediated inflammatory disease characterized by increased cell signalling via cytokines and chemokines on a background of up-regulated gene expression. There is substantial evidence that psoriasis should be regarded as more than a cutaneous disease; major psychological...
Autores principales: | Leman, JA, Burden, AD |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2643098/ https://www.ncbi.nlm.nih.gov/pubmed/19337424 |
Ejemplares similares
-
Infliximab for the treatment of plaque psoriasis
por: Gall, Jennifer S, et al.
Publicado: (2008) -
Infliximab in the treatment of plaque type psoriasis
por: Saraceno, Rosita, et al.
Publicado: (2009) -
Infliximab and biosimilar infliximab in psoriasis: efficacy, loss of efficacy, and adverse events
por: Subedi, Smriti, et al.
Publicado: (2019) -
Dramatic Response of Nail Psoriasis to Infliximab
por: Safa, Gilles, et al.
Publicado: (2011) -
A systematic review on the efficacy and safety of Infliximab in patients with psoriasis
por: Wang, Jin, et al.
Publicado: (2015)